ArticleScientific reports2024

Impact of anemia requiring transfusion or erythropoiesis-stimulating agents on new-onset cardiovascular events and mortality after continuous renal replacement therapy.

Junseok Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.